Veeva Systems Inc. (NYSE:VEEV) Holdings Lifted by Royal London Asset Management Ltd.

Royal London Asset Management Ltd. lifted its holdings in shares of Veeva Systems Inc. (NYSE:VEEV - Free Report) by 4.9% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 70,282 shares of the technology company's stock after buying an additional 3,295 shares during the period. Royal London Asset Management Ltd.'s holdings in Veeva Systems were worth $14,777,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. MassMutual Private Wealth & Trust FSB grew its holdings in shares of Veeva Systems by 72.5% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 119 shares of the technology company's stock valued at $25,000 after purchasing an additional 50 shares during the last quarter. Centricity Wealth Management LLC bought a new position in Veeva Systems during the 4th quarter worth $25,000. Smithfield Trust Co grew its stake in Veeva Systems by 145.5% during the 4th quarter. Smithfield Trust Co now owns 135 shares of the technology company's stock worth $27,000 after buying an additional 80 shares during the last quarter. True Wealth Design LLC lifted its stake in Veeva Systems by 3,375.0% in the third quarter. True Wealth Design LLC now owns 139 shares of the technology company's stock valued at $29,000 after buying an additional 135 shares during the last quarter. Finally, Retirement Wealth Solutions LLC acquired a new position in shares of Veeva Systems during the fourth quarter valued at $31,000. Institutional investors and hedge funds own 88.20% of the company's stock.

Veeva Systems Trading Up 0.6 %

VEEV stock traded up $1.37 during mid-day trading on Tuesday, reaching $240.41. 1,056,406 shares of the stock traded hands, compared to its average volume of 1,010,891. Veeva Systems Inc. has a 52-week low of $170.25 and a 52-week high of $258.93. The stock's fifty day moving average is $230.35 and its 200-day moving average is $222.59. The company has a market cap of $39.03 billion, a P/E ratio of 59.36, a P/E/G ratio of 1.89 and a beta of 0.88.

Remove Ads

Wall Street Analyst Weigh In

VEEV has been the topic of a number of analyst reports. Barclays increased their price objective on shares of Veeva Systems from $260.00 to $275.00 and gave the stock an "overweight" rating in a report on Friday, December 6th. Morgan Stanley lifted their price target on Veeva Systems from $195.00 to $201.00 and gave the company an "underweight" rating in a report on Thursday, March 6th. Truist Financial raised their target price on Veeva Systems from $210.00 to $217.00 and gave the company a "hold" rating in a research report on Thursday, March 6th. Robert W. Baird boosted their price target on Veeva Systems from $283.00 to $285.00 and gave the stock an "outperform" rating in a research report on Thursday, March 6th. Finally, Stifel Nicolaus upped their price objective on shares of Veeva Systems from $240.00 to $272.00 and gave the stock a "buy" rating in a report on Friday, December 6th. Two equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and sixteen have issued a buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $256.52.

Veeva Systems Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.